Boston Scientific (BSX) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $51.83 +0.27%
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.15 billion.
GUIDANCE:
Boston Scientific sees Q4 2022 EPS of $0.45-$0.48, versus the consensus of $0.49.
Boston Scientific sees FY2022 EPS of $1.71-$1.74, versus the consensus of $1.76.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
